Leading Peptides Expert Explores the Role of LC-MS in Drug Development and Delivery
New Interview Released with Ferring’s Peptide and LC-MS expert in the lead to SMi's Peptides 2017 event.
London, United Kingdom, May 04, 2017 --(PR.com)-- Jörgen Kjellgren Sjögren, Senior Research Scientist at Ferring Pharmaceuticals, has joined the expert speaker lineup for SMi Group’s 4th Peptides Event in July.
With over 15 years of expertise in peptides, Jörgen will bring insights into using Liquid Chromatography and Mass Spetrometry as a key technique to understanding the fate of impurities using examples from Ferring's synthetic therapeutic peptide portfolio.
In the lead to the event, the SMi Group spoke to Jörgen to get his perspective on the current peptides landscape in relation to his presentation.
"Today it is very important to have complete understanding of the synthesis and fate of impurities, from starting material to final drug substance (API) to be able to make safe drugs for the patient, make robust processes, and of course, to get authority approval of our new drug products.
"The take home message is that LC-MS/MS is necessary in the field of making pharmaceuticals from synthetic peptides, which most people are aware of today. I will show with several examples that LC-MS is a key instrument in understanding the fate of impurities during the whole process of making a drug, from starting material to final drug product. I hope that I can convince people, if they not already are doing it, that investing time in fate of impurities study will be a help in developing more robust processes and safer drugs for the patients. It has also been very important to have this knowledge when answering questions from authorities. Another thing I would like people to get from my presentation is that separation.”
The full interview is available to read on www.peptidesevent.com/prcom.
The line-up joining Jörgen at Peptides 2017 includes an elite group of international experts from UCB, Novartis, Boehringer-Ingelheim, Bristol-Myers Squibb, Nestle Skin Health, Sanofi, Zealand Pharma, Ipsen and more.
For further details or to register, visit the event website at www.peptidesevent.com/prcom.
4th Peptides Event
6-7 July 2017
Holiday Inn Kensington Forum, London UK
www.peptidesevent.com/prcom
For delegate registration enquiries, contact Fateja Begum on fbegum@smi-online.co.uk. For media enquiries, contact Honey de Gracia at hdegracia@smi-online.co.uk.
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
With over 15 years of expertise in peptides, Jörgen will bring insights into using Liquid Chromatography and Mass Spetrometry as a key technique to understanding the fate of impurities using examples from Ferring's synthetic therapeutic peptide portfolio.
In the lead to the event, the SMi Group spoke to Jörgen to get his perspective on the current peptides landscape in relation to his presentation.
"Today it is very important to have complete understanding of the synthesis and fate of impurities, from starting material to final drug substance (API) to be able to make safe drugs for the patient, make robust processes, and of course, to get authority approval of our new drug products.
"The take home message is that LC-MS/MS is necessary in the field of making pharmaceuticals from synthetic peptides, which most people are aware of today. I will show with several examples that LC-MS is a key instrument in understanding the fate of impurities during the whole process of making a drug, from starting material to final drug product. I hope that I can convince people, if they not already are doing it, that investing time in fate of impurities study will be a help in developing more robust processes and safer drugs for the patients. It has also been very important to have this knowledge when answering questions from authorities. Another thing I would like people to get from my presentation is that separation.”
The full interview is available to read on www.peptidesevent.com/prcom.
The line-up joining Jörgen at Peptides 2017 includes an elite group of international experts from UCB, Novartis, Boehringer-Ingelheim, Bristol-Myers Squibb, Nestle Skin Health, Sanofi, Zealand Pharma, Ipsen and more.
For further details or to register, visit the event website at www.peptidesevent.com/prcom.
4th Peptides Event
6-7 July 2017
Holiday Inn Kensington Forum, London UK
www.peptidesevent.com/prcom
For delegate registration enquiries, contact Fateja Begum on fbegum@smi-online.co.uk. For media enquiries, contact Honey de Gracia at hdegracia@smi-online.co.uk.
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
Contact
SMi Group
Honey de Gracia
+44 (0) 207 827 6162
http://www.peptidesevent.com/prcom
Honey de Gracia
+44 (0) 207 827 6162
http://www.peptidesevent.com/prcom
Contact
Categories